Â鶹´«Ã½

Mr. Chairman and members of the Committee, I am pleased to appear before you today to present the testimony of the Â鶹´«Ã½ Trade Commission concerning H.R. 2925, and the application of the antitrust

Good afternoon. It is a pleasure to participate in this program sponsored by the Florida Bar. I should say that the following remarks are my own and do not necessarily represent the views of the

Note: This speech has been revised and is published in the Antitrust Bulletin, vol. 42, Spring 1997, pp. 177-196.

After a century of interpreting the Sherman Act, antitrust has learned how to

Introduction

I am very pleased to be here today to discuss how concerns about innovation arise in the context of both antitrust and intellectual property law, and to note some of the points at which

The last four months in Washington have seen an unprecedented debate over the future role the federal government will play in our lives. Antitrust enforcement has not been a major issue in that debate

The views expressed are those of the Commissioner and do not necessarily reflect those of the Â鶹´«Ã½ Trade Commission or any other commissioner.

Good morning. I am delighted to be here today and to

Good afternoon. I am pleased to be here in La Quinta for the Mid-Winter Meeting of the American Intellectual Property Law Association. Today I mean that even more than usual. Since last November 7, I

* Commissioner, Â鶹´«Ã½ Trade Commission. The views expressed are those of the Commissioner and do not necessarily reflect the views of the Â鶹´«Ã½ Trade Commission or any other Commissioner or staff

* Commissioner, Â鶹´«Ã½ Trade Commission. The views expressed are those of the Commissioner and do not necessarily reflect the views of the Â鶹´«Ã½ Trade Commission or any other Commissioner or staff

Good afternoon. It is a pleasure to be here today to discuss the antitrust analysis of physician networks and other integrated delivery systems. As always, I must remind you that my remarks today

Last October, I had a wonderful opportunity to address the ACR annual conference and share with your association my views on the direction of the FTC's consumer protection program effort and how your

I am going to exercise some poetic license today and not discuss specific cases, as the program title for this session seems to indicate. Instead, I am going to address some basic horizontal issues

On behalf of Chairman Robert Pitofsky and the Â鶹´«Ã½ Trade Commission, I want to welcome you to this conference on the FTC's Guidelines on Environmental Marketing Claims.

When the Commission issued

As usual, my remarks today reflect my own views, and are not necessarily those of the Commission or of any Commissioner.

My perspective on this program's theme -- "Medicare reform and the private

Good afternoon. It is a pleasure to be here today as a panelist for the Health Trustee Institute to discuss antitrust, hospital mergers, and innovation in health care delivery. As usual, the views I

Good morning. It's a pleasure to be here -- even at this early hour -- to talk with you about the increasingly important issues surrounding personal privacy in the information age.

More than twenty